Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.18 USD | +0.76% | +4.67% | -7.26% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.26% | 3.61B | |
-2.16% | 103B | |
+0.69% | 95.71B | |
+1.69% | 22.02B | |
-16.96% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.63% | 15.52B | |
+3.56% | 13.86B | |
+35.00% | 12.04B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Ultragenyx Pharmaceutical : Morgan Stanley Adjusts Price Target on Ultragenyx Pharmaceutical to $175 From $91 on GTX-102 Potential, Maintains Overweight Rating